Comparing the dynamics of biomarkers of neuron-specific enolase and S-100 protein in neonates with hypoxic-ischemic encephalopathy, depending on the start of therapeutic hypothermia (0-6 h vs. 6-24 h after delivery)
Background. To date, it remains unclear whether serum levels of neuron-specific enolase (NSE) and S-100 protein definitely correspond to the severity and possible outcomes of hypoxic-ischemic encephalopathy (HIE), as well as their dynamics during the acute period of HIE, depending on the time when t...
Guardado en:
Autor principal: | D.M. Surkov (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Zaslavsky O.Yu.,
2019-03-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Benefits of starting hypothermia treatment within 6 h vs. 6-12 h in newborns with moderate neonatal hypoxic-ischemic encephalopathy
por: Wen Jia, et al.
Publicado: (2018) -
Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns
por: Verónica Chaparro-Huerta, et al.
Publicado: (2017) -
Hypothermia therapy for newborns with hypoxic ischemic encephalopathy
por: Rita C. Silveira, et al.
Publicado: (2015) -
Hypothermia therapy for newborns with hypoxic ischemic encephalopathy
por: Rita C. Silveira, et al.
Publicado: (2015) -
Therapeutic hypothermia for neonates with hypoxic ischemic encephalopathy
por: Ming-Chou Chiang, et al.
Publicado: (2017)